Cephalosporins are widely used antibiotics. Cephalosporin molecules containing cephalosporene are semi-synthetic antibiotics belonging to the class of beta-lactam antibiotics, which are derivatives of 7-amino-cephalosporin acid (7-aca) in the class of beta-lactam antibiotics, so they have similar bactericidal mechanisms.
This report contains market size and forecasts of Ceftaroline Fosamil in global, including the following market information:
Global Ceftaroline Fosamil Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Ceftaroline Fosamil Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Ceftaroline Fosamil companies in 2021 (%)
The global Ceftaroline Fosamil market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Injection Type Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ceftaroline Fosamil include Roche, Pfizer, Abbvie, Johnson, Sanofi, Merck, Novartis, Gilead and GSK, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ceftaroline Fosamil manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ceftaroline Fosamil Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Ceftaroline Fosamil Market Segment Percentages, by Type, 2021 (%)
Injection Type
Oral Type
Global Ceftaroline Fosamil Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Ceftaroline Fosamil Market Segment Percentages, by Application, 2021 (%)
Drug-resistant staphylococcus aureus infection
Gram-Negative Bacterial Infection
Others
Global Ceftaroline Fosamil Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Ceftaroline Fosamil Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ceftaroline Fosamil revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Ceftaroline Fosamil revenues share in global market, 2021 (%)
Key companies Ceftaroline Fosamil sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Ceftaroline Fosamil sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Pfizer
Abbvie
Johnson
Sanofi
Merck
Novartis
Gilead
GSK
Amgen
Hayao